Image provided by: Texas A&M University
About The Battalion. (College Station, Tex.) 1893-current | View Entire Issue (Oct. 8, 2003)
6 &1 College Sk! & Board Week BMIHSM Ski 20 Mountains « 5 He sorts tor me Price ot 1 Breck, Vail,^ Beavercreek, « - TO Arapahoe Basin M. & Keystone ^^u.6Ski wm-Mu 1 -QOO-'7’S^-9-^S3 Discover Vietnam! Winter Break Study Abroad Program December 27, 2003-January 12, 2004 4 hours of 400 or 600 level course credit in agriculture Experience Vietnamese history and culture Explore environment and natural resource sites Learn about tropical agricultural production systems For more information contact: The International Office of The Agriculture Program Jack K Williams Administration Building, Room 12 (979) 845-3763 r-dagostino@tamu.edu or gm-mcwhorter@tamu.edu NATION Wednesday, October 8, 2003 THE BATTALION Asian and Hispanic immigrants more likely to own homes in U.S. By Genaro C. Armas THE ASSOCIATED PRESS Trtp or Treat? Our Student Fares are so low, it's SCARY! Home for the Holiday Fares available NOW!! bTRAVELCUTS See the world your way Toll Free 1-800-592-CUTS (2887) usareservations@travelcuts.com www.travelcuts.com Fares are rountrip, and are subject to availability. Taxes are additional. The Peace Corps is search of graduates with Agriculture, Environment and Health backgrounds for 2-year projects in one of our 70 host nations. Talk to Peace Corps Recruiter James Barta at the following times: • Wednesday, Oct. 8, 5:30 to 6:45 p.m. Info Meeting, MSC Room 230 • Thursday, Oct. 9, 10 a.m. to 3 p.m Career Fair, MSC Flagroom • Thursday, Oct. 9, 7 to 8:15 p.m. MSC, Room 229 WASHINGTON — Asians and Hispanics who immigrate to the United States and become naturalized citizens are more like ly to own homes than members of the same groups who are bom in the country, the Census Bureau reported Tuesday. About 63 percent of foreign- bom Hispanics who are natural ized citizens owned their homes in 2002, compared with 54 per cent of Latinos bom in the United States, the bureau said. The dif ference was even greater between naturalized immigrant Asians and native-born Asians: 70 percent to 57 percent. Like U.S. homeownership overall, rates in these race and ethnic groups have increased gen erally since the mid-1990s, helped by falling interest rates and an economy that was boom ing for most of the period. Still, some experts were mild ly surprised that people bom out side the country were more apt to own homes than native-born peo ple in the same racial or ethnic group. Possible explanations include a strong desire among immi grants to own homes, said Robert Lang, a metropolitan develop ment and planning professor at Virginia Tech University. “Remember what we export in terms of pop culture often revolves around owning a home, especially older popular culture about suburbia,” Lang said. “A lot of people come to this country eager to participate fully in American life.” Visit the TAMU Career Center 209 Koidus Building to pick up a Peace Corps Catalog. Generally, immigrants in the country longer, regardless of citi zenship status, are more likely be homeowners. For instance, 60 percent of naturalized citizens who arrived in 1975 or later owned their homes, compared with 77 percent of those who arrived before 1975. Waiting longer helps people build savings that can be used on down payments, said Janis Bowdler, housing policy analyst for the National Council of La Raza, a Hispanic advocacy group. And while the foreign-bom population is concentrated in urban areas in gateway states like New York and California, Bowdler noted sizable increases were evident in the immigrant population over the 1990s in more affordable states such as North Carolina and Nevada. “Generally, homeownership in many foreign countries requires a much larger down pay ment than in the United States, and many immigrants are sur prised by the opportunity,” said Lawrence Yun, senior economist at the National Association of Realtors. The Census Bureau study found the overall homeownership rate rose from 64 percent in 1994 to a record high of 67.9 percent in 2002. Rates were also at record lev els for non-Hispanic whites, regardless of citizenship status (74.5 percent), as well as Asians (54.7 percent) and Hispanics (48.2 percent). The 47.3 rate for blacks in 2002 was less than a half-point lower than in 2001. Between 1994 and 2002, the homeownership rate rose from Home of their own Naturalized Asians, Hispanics and blacks are more likely to own homes than their native- born counterparts, according to the Census Bureau. ■■I U.S. born I I Naturalized citizen F 1 Non-citizen Asian and Pacific Islander 22.2% Non-hispanic white E 73.7% 46.1% SOURCE: U.S. Census Bureau 65.7 percent to 70.3 percent for all native-born residents, regard less of race or ethnicity; from 66.8 percent to 67.6 percent among naturalized citizens; and from 32.9 percent to 34.9 percent among noncitizens. There were similar increases across most race and ethnic cate gories, although homeownership for U.S.- bom Asians declined from 62 percent to about 57 per cent. A large number of Asians live in some of the most expen sive metropolitan areas in the country, including New York, Los Angeles and San Francisco. Findings come from a year long survey of about 60,000 homes. Questions about citizen ship status on this survey were first asked in 1994. Deliberation Continued from page 1 4A/XI 1 yttaA 1 —KTw! AGGIEL OUTFITTERS wwiw.aggieIandoutfftters.com 2 LOCATIONS 2 SERVE YOU 208 GEORGEBUSH DR (ACHOSS FROM KYlEFl£LD) & POST OAK MALL AGGIEL AND. TEXAS 00 4- t 4^ For annual checkups, birth control, emergency contraception, pregnancy testing and testing & treatment for sexually transmitted infections. 4112 E. 29th, Bryan, TX 77802 1.800.230.PLAN www.pphouston.org O Planned Parenthood® of Houston and Southeast Texas, Inc. along the University Drive exit of the Earl Rudder Freeway. Another estimate of 82 mph was given by a witness for the prosecution Friday morning, as reported in the Bryan-College Station Eagle. An engineer who does accident-reconstruction consulting work later testified Thompson was traveling between 68 mph and 72 mph. The driver’s blood alcohol level in the initial test, which took place one hour and 15 min utes after the accident, was three times the legal limit of .08, and it was .222 three hours later, as reported in the Eagle. The attorneys for the defense and prosecution spent a signifi cant amount of Monday debating whether the second blood test should be admitted as evidence. Because the second test was taken without the consent of the driver and without a court order, the defense argued it was invalid for court purposes. Prosecutors disagreed, saying the officers’ actions of taking another test were legitimate because the longer offi cers waited for a warrant, the more Thompson’s blood alcohol level would have decreased. “That’s a reasonable thing to ask,” said Assistant District Attorney Shane Phelps of the blood withdrawal, as reported in the Eagle. Phelps also said the jury could use Thompson’s refusal to submit as evidence what he was thinking at the time. Both Garza and Thompson were taken to St. Joseph Regional Health Center after the accident. Defense attorneys Jim James and Cameron Reynolds doubted the reliability of the machine that was used for the test at St. Joseph’s, as reported in the Eagle. The medical techinicans who ran the machine testified that it was producing accurate results. One of the five A&M stu dents who served as witnesses in the case estimated that Thompson had 24 beers over the 12-hour span he had been drink ing. The defense called this statement a guess. Two students reported to police that they had notid Thompson driving his trucl aggressively earlier the evening of June 8. One of the Thompson’s pas sengers earlier in the night,; Tiffany Powell, recalled tha| she told Thompson: “I don’t feel like going through the wind-C shield tonight,” the Eagle report ed. She said he responded by saying, “Don’t worry, I won’t do anything to hurt my truck.” Intoxication manslaughter is punishable by two years of pro-, bation to 20 years in prison. .* The jury also decided) Monday that Thompson’s; vehicle was used as a deadly weapon, Phelps said. This charge means Thompson will have to serve at least half of any prison sentence he receives before he will be eli gible for parole. Recall Contra.C6ptlV6 InjGClllOn BogUK corvtr'ol you-tKiiAk a&ouL jus't M'KBys.air Continued from page 1 medroxyprogesterone acetate injectable suspension DEPO-PROVERA s Contraceptive Injection (medroxyprogesterone acetate injectable suspension, USP) This product is intended to prevent pregnancy. It does not protect against HIV infection (AIDS) and other sexually transmitted diseases. What is DEPO-PROVERA Contraceptive Injection? DEPO-PROVERA Contraceptive Injection is a form of birth control that is given as an intramuscular injection (a shot) in the buttock or upper arm once every 3 months (13 weeks). To continue your contraceptive protection, you must return for your next injection promptly at the end of 3 months M3 weeks). DEPO-PROVERA contains medroxyprogesterone acetate, a chemical similar to (but not the same as) the natural hormone progesterone, which is produced by your ovaries during the second half of your menstrual cycle. DEPO-PROVERA acts by preventing your egg cells from ripening. If an egg is not released from the ovaries during your menstrual cycle, it cannot become fertilized by sperm and result in pregnancy. DEPO-PROvERA also causes changes in the lining of your uterus that make it less likely tor pregnancy to occur How effective is DEPO-PROVERA Contraceptive Injection? The efficacy of DEPO-PROVERA Contraceptive Injection depends on following the recommended dosage schedule exactly (see "How often do I get my shot of DEPO-PROvERA Contraceptive Injection?"). To make sure you are not pregnant when you first get DEPO-PROVERA Contraceptive Injection, your first injection must be given ONLY during the first 5 days of a normal menstrual period; ONLY within the first 5 days after childbirth if not breast-feeding; and, if exclusively breast-feeding, ONLY at the sixth week after childbirth. It is a long-term injectable contraceptive when administered at 3-month (13-week) interval! DEPO-PROVERA Contraceptive Injection is over 99% effective, making it one of the most reliable methods of birth control available. This means that the average annual pregnancy rate is less than one for every 100 women who use DEPO-PROVERA. The effectiveness of most contraceptive methods depends in part on how reliably each woman uses the method. The effectiveness of DEPO-PROvERA depends only on the patient returning every 3 months (13 weeks) for her next injection. Your health-care provider will help you compare DEPO-PROVERA with other contraceptive methods and give vou the information you need in order to decide which contraceptive method is the right choice for you. • if you have had cancer of the breast • if you have had a stroke • if you have or have had blood clots (phlebitis) in your legs • if you have problems with your liver or liver disease • if you are allergic to DEPO-PROVERA (medroxyprogesterone acetate or any of its other ingredients). What other things should I consider before using DEPO-PROVERA Contraceptive Injection? You will have a physical examination before your doctor prescribes DEPO-PROVERA. It is important to tell your health-care provider if you have any of the following: • a family history of breast cancer • an abnormal mammogram (breast x-ray), fibrocystic breast disease, breast nodules or lumps, or bleeding from your nipples • kidney disease • irregular or scanty menstrual periods • high blood pressure • migraine headaches d.Other Risks Women who use hormone-based contraceptives may have an increased risk of blood clots or stroke. Also, if a contraceptive method fails, there is a possibility that the fertilized egg will begin to develop outside of the uterus (ectopic pregnancy). While these events are rare, you should tell your health-care provider if you have any of the problems listed in the next section. What symptoms may signal problems while using DEPO-PROVERA i? Contraceptive Injection? Call your health-care provider immediately if any of these problems occur following an injection r "~ r ' * nigra stnn • epilepsy (convulsions or seizures) • diabetes or a family history of diabetes • a history of depression • if you are taking any prescription or over-the-counter medications This product is intended to prevent pregnancy. It does not protect against transmission of HIV (AIDS) and other sexually transmitted diseases such as chlamydia, genital herpes, genital warts, gonorrhea, hepatitis B, and syphilis. of DEPO-PROVERA: • sharp chest pain, coughing up of blood, or sudden shortness of breath (indicating a possible clot in the lung) • sudden severe headache or vomiting, dizziness or fainting, problems with your eyesight or speech, weakness, or numbness in an arm or leg (indicating a possible stroke) • severe pain or swelling in the calf (indicating a possible clot in the leg) • unusually heavy vaginal bleeding • severe pain or tenderness in the lower abdominal area • persistent pain, pus, or bleeding at the injection site What are the possible side effects of DEPO-PROVERA Contraceptive Injection? I.Weight Gain You may experience a weight gain while you are using DEPO-PROVERA. About two thirds of the women who used DEPO-PROVERA in clinical trials reported a weight gain of about 5 pounds during the first year of use. You ma^ continue to gain weight after the first year Women in one The following table shows the percent of women who got pregnant while using different kinds of contraceptive methods. It gives both the lowest expected rate of pregnancy (the rate expected in women who use each method exactly as it should be used) and the typical rate of pregnancy (which includes women who became pregnant because they forgot to use their birth control or because they did not follow the directions exactly). Percent of Women Experiencing an Accidental Pregnancy in the First Year of Continuous Use Method Lowest Expected Typical DEPO-PROVERA 0.3 0.3 Implants (Norplant) 0.2* 0.2* Female sterilization 0.2 0.4 Male sterilization 0.1 0.15 Oral contraceptive (pill) 3 Combined 0.1 Progestogen only 0.5 IUD 3 Progestasert 2.0 Copper T 380A 0.8 Condom (without spermicide) 2 12 Diaphragm (with spermicide) 6 18 Cervical cap 6 18 Withdrawal 4 18 Periodic abstinence 1-9 20 Spermicide alone 3 21 Vaginal Sponge used before childbirth 6 18 used after childbirth 9 28 No method 85 85 What if I want to become pregnant after using DEPO-PROVERA Contraceptive Injection? Because DEPO-PROVERA is a long-acting birth control method, it takes some time after your last injection for its effect to wear off. Based on the results from a large study done in the United States, for women who stop using DEPO-PROVERA in order to become pregnant, it is expected that about half of those who become pregnant will do so in about 10 months after their last injection; about two thirds of those who become pregnant will do so in about 12 months; about 83% of those who become pregnant will do so in about 15 months; and about 93% of those who become pregnant will do so in about 18 months after their last injection. The length of time you use DEPO-PROVERA has no effect on how longrt takes you to become pregnant after you stop using it What are the risks of using DEPO-PROVERA Contraceptive Injection? I .Irregular Menstrual bleeding The side effect reported most frequently by women who use DEPO-PROVERA for contraception is a change in their normal menstrual cycle. During the first year of using DEPO-PROVERA, you might have one or more of the following changes: irregular or unpredictable bleeding or spotting, an increase or decrease in menstrual bleeding, or no bleeding at all. Unusually heavy or continuous bleeding, however; is not a usual effect of DEPO-PROVERA; large study who used DEPO-PROVERA for 2 years gained an average total of 8.1 pounds over those 2 years, or approximately 4 pounds per year Women who continued for 4 years gained an average total of 13.8 pounds over those 4 years, or approximately 3.5 pounds per year Women who continued for 6 years gained an average total of 16.5 pounds over those 6 years, or approximately 2.75 pounds per year 2.Other Side Effects In a clinical study of over 3,900 women who used DEPO-PROVERA for up to 7 years, some women reported the following effects that may or may not have been related to their use of DEPO-PROVERA: Irregular menstrual bleeding, amenorrhea, headache, nervousness, abdominal cramps, dizziness, weakness or fatigue, decreased sexual desire, leg cramps, nausea, vaginal discharge or irritation, breast swelling and tenderness, bloating, swelling of the hands or feet, backache, depression, insomnia, acne, pelvic pain, no hair growth or excessive hair loss, rash, hot flashes, and joint pain. Other problems were reported by very few of the women in the clinical trials, but some of these could be serious. These include convulsions, jaundice, urinary tract infections, allergic reactions, fainting, paralysis, osteoporosis, lack of return to fertility, deep vein thrombosis, pulmonary embolus, breast cancer; or cervical cancer If these or any other problems occur during your use of DEPO-PROVERA, discuss them with your health-care provider w your use of DEPO-PROVERA, discuss them with your health-care pro\ Should any precautions be followed during use of DEPO-PROVERA In' “ ~ reported bleeding (amenorrhea) after I year of use, and 68% of the women studied reported no menstrual bleeding after 2 years of use. The reason that your periods stop is because DEPO-PROVERA causes a resting state in your ovaries. When your ovaries do not release an egg monthly, the regular monthly growth of the lining of your uterus does not occur and, therefore, the bleeding that comes with your normal menstruation does not take place. When you stop using DEPO-PROVERA your menstrual period will usually, in time, return to its normal cycle. 2.bone Mineral Changes Use of DEPO-PROVERA may be associated with a decrease in the amount of mineral stored in your bones. This could increase your risk of developing bone fractures. The rate of bone mineral loss is greatest in the early years of DEPO-PROVERA use, but after that, it begins to resemble the normaT rate of age-related bone mineral loss. J.Cancer Studies of women who have used different forms of contraception found that women who used DEPO-PROVERA for contraception had no increased overall risk of developing cancer of the breast, ovary, uterus, cervix, or liver However women under 35 years of age whose first exposure to DEPO-PROVERA was within the previous 4 to 5 years may have a slightly increased risk of developing breast cancer similar to that seen with oral contraceptives. You should discuss this with your health-c i-care provider 4.Unexpected Pregnancy —O-PROVERA Source: Trussell et al. Obstet Gynecol 1990:76:558-567. •From Norplant® package insert Who should not use DEPO-PROVERA Contraceptive Injection? Not all women should use DEPO-PROVEFVV You should not use DEPO-PROVERA if you have any of the following conditions: • if you think you might be pregnant • if you have any vaginal bleeding without a known reason Because DEPO-PROVERA is such an effective contraceptive method, the risk of accidental pregnancy for women who get their shots regularly fevery 3 months [ 13 weeks]) is very low. while there have been reports of an increased risk of low birth weight and neonatal infant death or other health problems in infants conceived close to the time of injection, such preg uncommon. If you think you may have become pregnanf while using DEPO-PR< contraception, see your health-care provider as soon as possjble. SAIIergic Reactions Some women using DEPO-PROVERA Contraceptive Injection have reported severe and potentially life-threatening allergic reactions known as anaphylaxis and anaphylactoid reactions. Symptoms include the sudden onset of hives or swelling and itching of the skin, breathing difficulties, and a drop in blood pressure. Contraceptive Injection? / .Missed Periods During the time you are using DEPO-PROVERA for contraception, you may skip a period, or your periods may stop completely. If you have been receiving your DEPO-PROVERA injections regularly every 3 months (13 weeks), then you are probably not pregnant. Howeven if you think that you may be pregnant see your health-care provider 2. Laboratory Test Interactions If you are scheduled for any laboratory tests, tell your health-care provider that you are using DEPO-PROVERA for contraception. Certain blood tests are affected by hormones such as DEPO-PROVERA. 3. Drug Interactions Cytadren (aminoglutethimide) is an anticancer drug that may significantly decrease the effectiveness of DEPO-PROVERA if the two drugs are given during the same time. 4. Nursing Mothers Although DEPO-PROVERA can be passed to the nursing infant in the breast milk, no harmful effects nave been found in these children. DEPO-PROVEKA does not prevent the breasts from producing milk, so it can be used by nursing mothers. However to minimize the amount of DEPO-PROVERA that is passed to the infant in the first weeks after birth, you should wait until 6 weeks after childbirth before you start using DEPO-PROVERA for contraception. How often do I get my shot of DEPO-PROVERA Contraceptive Injection? The recommended dose of DEPO-PROVERA is 150 mg every 3 months (13 weeks) given in a single intramuscular injection in the buttock or upper arm. To make sure that you are not pregnant at the time of the first injection, it is essential that the injection be given ONLY during the first 5 days of a normal menstrual period. If used following the delivery of a child, the first injection of DEPO-PROVERA MUST be given within 5 days after childbirth if you are not breast-feeding or 6 weeks after childbirth if you are exclusively breast-feeding. If you wait longer than 3 months (13 weeks) between injections, or longer than 6 weeks after delivery, your health-care provider should determine that you are not pregnant before giving you your injection of DEPO-PROVERA. for Rx only CB-7-S Pharmacia & Upjohn Company Kalamazoo, Ml 49001, USA Pharmacia & Upjohn election. Long lines were reported at polling places through the By late afternoon, Terri Carbaugh, a spokeswoman for the Secretary of State, said turnout of 60 percent was like! higher than the 50.7 percent wti voted in last November’s guber natorial election. Re-elected last year with than 50 percent of the vote, Davis fell victim to a groundswell of discontent. The actor’s improbable rise to political power played out before a rapt international audience. He announced his candidacy in August on “The Tonight Show With Jay Leno” after aides said il was certain he wouldn’t run. Other major candidates seek ing to replace Davis were the; Democratic lieutenant governor. Cruz Bustamante, conservative Republican state Sen. Tom McClintock and Green Party can didate Peter Camejo. The campaign included a parade of bit players among the 135 candidates, including Hustler publisher Larry Flynt, former child actor Gary Coleman, a pub licity-hungry pom actress who wanted to tax breast implants and' an artist who dressed in all blue and described his candidacy as the ultimate piece of performance art. “Fm horrified at the thought that Schwarzenegger can be our governor,” said Gretchen Purser, 25, of Berkeley, who voted, against recall. “I’m sick of Republicans trying to take over the state.” Fra By TH The Dennis 1 started with a rc football program With a 2-3 re al the hands of doesn’t seem to 'Tm not a go "If 1 was 1 probal today, but I've blow how to har tough this man Indeed Franc tough times befo In his first s Franchione’s tea 1998, the Hon Franchione’s firs season also aw; sear at Alabama. ' At TCU and seasons of the tw »in seasons and r tall programs. Fc the national spot!: letum to national In both instanc erunder their nev they hit their si opponents in thei The Aggies ha At Alabama h hftil were ex their first-year co , but a 3-5 rei games was much came a showdos in Tuscalo Crimson Tide woi tie win streak ih an Independi That 2001 seas in place for a 1 ( paign despite nui on the Alabama p from playing in a Championship. “1 think the ma you start and whe five coordinator vti Franchione Here c °nie m ee t C y^hursd ^orial * ,r 0fft 10